-
Lipocomb 10 mg/10 mg hard capsules PPA0465/460/001 – Lipocomb 20 mg/10mg hard capsules PPA0465/460/002 – Two batches
Sep 15, 2023, 00:00 -
Valproate (Epilim) – Ongoing review of potential risk of NDD due to paternal exposure
Sep 15, 2023, 00:00 -
CUTAQUIQ 165mg/ml solution for injection – Adjustment of infusion rate
Sep 14, 2023, 14:50 -
SCHILLER CARDIOVIT AT-102 ECG – Priority 2 – Warning
Sep 13, 2023, 00:00 -
Ketofall 0.25 mg/ml eye drops, solution in single-dose container – PA1815/002/001 – Three batches
Sep 8, 2023, 10:54 -
Fluoroquinolone antibiotics – IMF – Reminder about restrictions of use and risk of rare side effects
Sep 1, 2023, 00:00 -
Product Information Updates – MIMS – Supporting the safe and effective use of medicines
Sep 1, 2023, 00:00 -
PRAC meeting highlights 28-31 August 2023
Aug 28, 2023, 00:00 -
Reminder of serious health risks with Melanotan 2 self-tan products
Aug 10, 2023, 00:00 -
Simponi (golimumab) – Changes to pre-filled pen injection instructions
Aug 9, 2023, 00:00 -
EpiPen 300 and 150 micrograms solution for injection in pre-filled pen – Changes to hold-time instructions
Jul 18, 2023, 14:56 -
Sabril 500mg film-coated tablets – PA 540/23/1 – One batch
Jul 13, 2023, 00:00 -
PRAC meeting highlights 3-6 July 2023
Jul 3, 2023, 00:00 -
Update – Versifel FeLV Suspension for Injection for Cats – VPA10387/088/001
Jun 30, 2023, 00:00 -
Systemic and inhaled fluoroquinolone antibiotics – Reminder on restrictions of use
Jun 18, 2023, 00:00 -
Adakveo (crizanlizumab) – Revocation of EU marketing authorisation
Jun 15, 2023, 00:00 -
Drug Safety Newsletter – Edition 112 – 9 June 2023
Jun 9, 2023, 00:00 -
Fluphenazin-neuraxpharm D25 Solution for Injection (Exempt Medicinal Product) – Pharmacy level recall – One batch
Jun 8, 2023, 14:46 -
PRAC meeting highlights 5-8 June 2023
Jun 5, 2023, 00:00 -
Clomid 50mg tablets - New contraindication and new visual side effects
Jun 1, 2023, 11:56
